Microbiome-mediated regulation of pathogen virulence: Molecular mechanisms and clinical implications

The human microbiome profoundly influences pathogen virulence and disease susceptibility through diverse molecular mechanisms. This review, focused on literature from 2016 to 2026, synthesizes knowledge on microbiome-mediated regulation examining major pathogens including Vibrio cholerae, enterohemorrhagic Escherichia coli, Salmonella species, Clostridioides difficile, and Staphylococcus aureus. A triangular interaction model is presented, linking host immunity, resident microbiome, and invading pathogen to frame infection outcomes. Commensal bacteria regulate pathogen behavior through quorum sensing interference, metabolite-mediated regulation via short-chain fatty acids and bile acids, competitive exclusion, immune response modulation, and direct antimicrobial production. Key species-Lactobacillus spp. Bifidobacterium spp. Bacteroides thetaiotaomicron, and Faecalibacterium prausnitzii-employ distinct molecular strategies against these pathogens. Organ-on-chip platforms and multi-omics advances reveal context-dependent interactions. Clinical applications including rationally designed probiotics, fecal microbiota transplantation, and precision microbiome engineering show promise despite challenges of inter-individual microbiome variability, representing a paradigm shift toward ecosystem-based infectious disease management.